INOVIO PHARMACEUTICALS, INC.: capex

Value{"amount": 487832, "concept": "us-gaap:PaymentsToAcquirePropertyPlantAndEquipment", "currency": "USD"}
Period2024-01-01 – 2024-09-30
Statuscurrent
EntityINOVIO PHARMACEUTICALS, INC.
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference: 0001055726-24-000052 · Open the official SEC filing →
Retrieved: 2026-08-19T10:22:47.430238+02:00
Raw response sha256: f7bde1a401b286c74a2fd824ee1df541…
Also addressable by official identifiers: https://factanker.com/fact/sec/cik-0001055726/capex/2024-09-30 (CIK, metric, reporting date)
Cite as: FACTANKER, https://factanker.com/fact/5f17842e-c13a-4eac-96ba-46f70b72b60b

History

From the Record
32 US software companies haven’t lost money in a decade. One of them is steadier than all the rest.
Read the findingSearch 53 million companies